ASHLEA RITTER: Open Payments
NPI 1396464475 · NEOSHO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 43 payments from 14 companies in 2025. Trend: 2023 $1,732 · 2024 $597 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $165 |
| ABBVIE INC. | 10 | $157 |
| Alkermes, Inc. | 5 | $154 |
| Vanda Pharmaceuticals Inc. | 4 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $41 |
| Indivior Inc. | 2 | $34 |
Products named: SPRAVATO, VRAYLAR, ARISTADA, CAPLYTA, REXULTI, COBENFY, FANAPT, INGREZZA.
Industry payments across MO — which companies pay providers there.
